Scanfil is a leading Finnish electronics manufacturing services (EMS) provider that offers a wide range of products and services to support the design, production, and distribution of electronic components. With over 45 years of experience in the industry, Scanfil has established itself as a trusted partner for companies operating in various sectors, including aerospace, defense, medical technology, and life sciences.
Scanfil's primary mission is to provide high-quality products and services that meet the needs of its customers, while also promoting sustainable growth and development. The company's core values include innovation, customer satisfaction, and social responsibility.
Scanfil offers a comprehensive range of products and services, including:
The company's products and services are designed to support the design, production, and distribution of electronic components, and are used in a wide range of applications, including industrial automation, medical devices, and aerospace systems.
Scanfil's products and services offer several benefits, including:
The company's products and services are designed to support the success of its customers, and are used in a wide range of applications across various industries.
Scanfil has implemented a Geared for Growth strategy for the period 2024-2028, which aims to drive growth and improve efficiency through a combination of organic and inorganic growth initiatives. The strategy includes investments in new technologies, expansion into new markets, and the development of new products and services.
The company's focus on innovation, customer satisfaction, and social responsibility will continue to guide its decision-making and drive its growth and success.
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Number of Shares (million) | 65.0 | 65.3 | 65.3 | 65.4 | 65.7 | 65.7 | 65.7 |
| Target Valuation (MEur) | 378.2 | 436.2 | 397.6 | 492.1 | 586.0 | 669.0 | 669.0 |
| Targer Price | 5.82 | 6.68 | 6.09 | 7.52 | 8.91 | 10.18 | 10.18 |
| Potential, % | -11.5 | -14.7 | -26.2 | -24.7 | -25.5 | -14.9 | -14.9 |
| Recommendation | Hold | Hold | Sell | Sell | Sell | Hold | Hold |
| MCAP (MEur) | 427.4 | 511.1 | 538.5 | 653.1 | 786.2 | 786.2 | 786.2 |
| Price | 6.58 | 7.83 | 8.25 | 9.98 | 11.96 | 11.96 | 11.96 |
| EV | 513.0 | 563.0 | 560.0 | 663.0 | 941.0 | 935.0 | 926.0 |
| P/S | 0.51 | 0.57 | 0.69 | 0.82 | 0.71 | 0.65 | 0.63 |
| EV/S | 0.61 | 0.62 | 0.72 | 0.83 | 0.85 | 0.77 | 0.74 |
| EV/EBIT | 11.33 | 9.19 | 10.66 | 12.18 | 12.39 | 11.42 | 10.61 |
| P/E | 12.21 | 10.6 | 13.99 | 16.05 | 13.93 | 12.0 | 11.26 |
| P/B | 1.89 | 1.92 | 1.85 | 2.08 | 2.2 | 1.86 | 1.59 |
| P/OCF | 41.9 | 7.42 | 5.85 | 10.19 | -337.42 | 37.65 | 32.49 |
| EV/OCF | 50.3 | 8.17 | 6.08 | 10.34 | -404.01 | 44.79 | 38.26 |
| P/FCF | -51.5 | 10.87 | 9.88 | 17.7 | -7.94 | 129.31 | 83.64 |
| EV/FCF | -61.82 | 11.97 | 10.27 | 17.95 | -9.51 | 153.82 | 98.5 |
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Revenue | 843.7 | 901.5 | 780.0 | 797.1 | 1108.8 | 1208.7 | 1254.1 |
| Rev. Growth, % | 21.3 | 6.9 | -13.5 | 2.2 | 39.1 | 9.0 | 3.8 |
| Ebit | 45.3 | 61.2 | 52.5 | 54.4 | 76.0 | 81.9 | 87.3 |
| Ebit Growth, % | 14.4 | 35.1 | -14.2 | 3.6 | 39.7 | 7.8 | 6.6 |
| Ebit, % | 5.4 | 6.8 | 6.7 | 6.8 | 6.9 | 6.8 | 7.0 |
| Profit | 35.0 | 48.2 | 38.5 | 40.7 | 56.4 | 65.5 | 69.8 |
| EPS | 0.54 | 0.74 | 0.59 | 0.62 | 0.86 | 1.0 | 1.06 |
| Profit Growth, % | 17.8 | 37.7 | -20.1 | 5.7 | 38.6 | 16.1 | 6.6 |
| Profit, % | 4.1 | 5.3 | 4.9 | 5.1 | 5.1 | 5.4 | 5.6 |
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Inventory | 229.3 | 209.0 | 168.1 | 176.5 | 264.9 | 287.2 | 304.4 |
| Acc. Receivable | 164.8 | 173.5 | 165.4 | 175.6 | 280.2 | 269.3 | 275.2 |
| Cash | 20.8 | 21.2 | 48.5 | 74.7 | 9.9 | 15.9 | 25.4 |
| Equity | 226.6 | 266.0 | 291.0 | 314.5 | 357.8 | 423.3 | 493.2 |
| ROE, % | 15.4 | 18.1 | 13.2 | 12.9 | 15.8 | 15.5 | 14.2 |
| ROCE, % | 13.6 | 18.1 | 14.6 | 13.6 | 14.5 | 13.9 | 13.3 |
| Net Debt | 85.7 | 51.6 | 21.2 | 9.4 | 155.1 | 149.1 | 139.7 |
| Gearing, % | 37.8 | 19.4 | 7.3 | 3.0 | 43.4 | 35.2 | 28.3 |
| Equity ratio, % | 43.1 | 51.4 | 54.0 | 52.9 | 42.8 | 47.8 | 54.1 |
| Acc. Payable | 183.7 | 166.7 | 153.7 | 174.9 | 235.0 | 224.9 | 213.5 |
| Total Assets | 525.5 | 518.0 | 539.1 | 594.5 | 836.2 | 885.9 | 910.8 |
| ROA, % | 6.7 | 9.3 | 7.1 | 6.8 | 6.7 | 7.4 | 7.7 |
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 10.2 | 68.9 | 92.1 | 64.1 | -2.3 | 20.9 | 24.2 |
| Investment Cash Flow | -18.5 | -21.9 | -37.6 | -27.2 | -96.7 | -14.8 | -14.8 |
| Free Cash Flow | -8.3 | 47.0 | 54.5 | 36.9 | -99.0 | 6.1 | 9.4 |
| OCF/CAPEX | 0.55 | 3.15 | 2.45 | 2.36 | 0.0 | 1.41 | 1.64 |
| Financial Cash Flow | 3.9 | -46.4 | -27.6 | -9.6 | 73.3 | 0.0 | 0.0 |
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
The data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.
Contact: quant@quantfactory.eu